Acta Pharmacologica et Toxicologica · 1983 · 101 citations · 18 references
MedicineNeurosciencePharmacologyNeuropharmacologyPharmacodynamicsPsychopharmacologyBasal GangliaDopaminergic PharmacologyDopaminergic SignalingMonoamine NeurochemistryNeuromodulationSerotonergic PharmacologyDopamine PharmacodynamicsDopaminergic ModulationDopaminergic Neuroendocrine ControlDopaminergic NeurophysiologyDopaminergic System EffectsNoradrenergic ModulationRegulation Of Motor ActivitySerotonin-dopamine Receptor Modulation
B-HT 920 at low doses inhibited the accumulation of DOPA following treatment with reserpine and a DOPA decarboxylase inhibitor in the dopamine-, but not in the noradrenaline-predominant regions of the rat brain. B-HT 933 selectively inhibited this DOPA accumulation in the noradrenaline-predominant regions. These effects of B-HT 920 and B-HT 933 were completely antagonized by haloperidol and yohimbine, respectively. The rat motor activity was reduced by B-HT 920 and it was restored following apomorphine. B-HT 933 decreased the motor activity by a yohimbine-sensitive mechanism. The results indicate that B-HT 920 can selectively and potently stimulate the dopamine autoreceptors whereas B-HT 933 can selectively stimulate the noradrenaline autoreceptors.
18
Evidence for dopamine receptor stimulation by apomorphine
Nils‐Erik Andén, A. Rubenson, Kjell Fuxé et al. · Journal of Pharmacy and Pharmacology · 1967 · 913 citations
Arvid Carlsson, James N. Davis, W. Kehr et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1972 · 648 citations